What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks

Overview



Robert (Bob) H. Cohen will speak on McDermott Will & Emery and BDO’s co-hosted program, “What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks.”

With over 200 special purpose acquisition company (SPAC) IPOs and over 100 SPAC mergers and counting over the last year, SPACs are hotter than ever. But are they the right approach for most Life Sciences companies seeking capital?

Join BDO and McDermott Will & Emery for a discussion with Anna Marie Wagner, Senior Vice President, Corporate Development of Ginkgo Bioworks, around SPACs in the Life Sciences industry.

We’ll discuss:

  • How to evaluate whether a SPAC is the right capital raising vehicle
  • How the new administration has affected the SPAC market
  • Accounting considerations that can potentially derail valuation
  • How to mitigate risks and challenges associated with a SPAC deal

The recording is available here to those with a BDO account.

Dig Deeper

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Symposium

London, United Kingdom / McDermott Event / September 29, 2022

HPE Europe 2022

MassBio Hub, Cambridge, MA / McDermott Event / September 7, 2022

Life Sciences Boot Camp 2022

San Diego, CA / McDermott Event / June 14, 2022

BIO BASH 2022

Washington, DC / FDLI / June 14 - 15, 2022

Exploring Advanced Topics in Food and Drug Law